This CAF-induced CRC cell migration can be blocked by knocking down FASN in CAFs in vitro or by impeding fatty acid uptake by CRC cells using a CD36 monoclonal antibody in vivo [135]. The gene discussed is FASN; the disease is colorectal carcinoma.